Danaher Co. (DHR) to Issue Quarterly Dividend of $0.27 on July 26th

Danaher Co. (NYSE:DHR) declared a quarterly dividend on Tuesday, May 7th, RTT News reports. Shareholders of record on Friday, June 28th will be paid a dividend of 0.27 per share by the conglomerate on Friday, July 26th. This represents a $1.08 annualized dividend and a yield of 0.43%.

Danaher has increased its dividend payment by an average of 13.4% per year over the last three years and has increased its dividend annually for the last 1 consecutive years. Danaher has a payout ratio of 12.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Danaher to earn $8.71 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 12.4%.

Danaher Stock Up 0.3 %

Shares of NYSE DHR opened at $249.58 on Thursday. The stock has a market cap of $184.86 billion, a P/E ratio of 42.30, a PEG ratio of 3.82 and a beta of 0.83. The business’s fifty day simple moving average is $248.27 and its 200-day simple moving average is $233.19. Danaher has a 12-month low of $182.09 and a 12-month high of $259.00. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same quarter last year, the company earned $2.36 EPS. Danaher’s revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, equities analysts predict that Danaher will post 7.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent analyst reports. TD Cowen increased their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. KeyCorp increased their price objective on Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Robert W. Baird boosted their target price on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. Royal Bank of Canada raised their price objective on shares of Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Finally, StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $267.31.

Insider Buying and Selling

In other news, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the transaction, the director now owns 116,202 shares of the company’s stock, valued at $28,304,483.16. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Danaher news, Director Walter G. Lohr sold 3,289 shares of Danaher stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $251.15, for a total value of $826,032.35. Following the sale, the director now owns 14,129 shares of the company’s stock, valued at approximately $3,548,498.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Alan G. Spoon sold 708 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the transaction, the director now directly owns 116,202 shares of the company’s stock, valued at $28,304,483.16. The disclosure for this sale can be found here. Insiders have sold a total of 103,984 shares of company stock valued at $25,997,094 over the last quarter. 10.90% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.